Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Acute pharyngitis in children.

BIBLIOGRAPHIC SOURCE(S)

  • Michigan Quality Improvement Consortium. Acute pharyngitis in children. Southfield (MI): Michigan Quality Improvement Consortium; 2007 Jan. 1 p.

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Michigan Quality Improvement Consortium. Acute pharyngitis in children. Southfield (MI): Michigan Quality Improvement Consortium; 2004 Apr. 1 p

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

The level of evidence grades (A-D) are provided for the most significant recommendations and are defined at the end of the "Major Recommendations" field.

Assessment

Assess past history of rheumatic fever (especially carditis or valvular disease) or household contact with a history of rheumatic fever to identify high-risk patients.

Assess the likelihood of strep pharyngitis using the following items:

  • Sudden onset
  • Sore throat
  • Fever
  • Patchy discrete exudate
  • Headache
  • Nausea, vomiting, and abdominal pain
  • Inflammation of pharynx and tonsils
  • Tender, enlarged anterior cervical nodes
  • Patient aged 5–15 years
  • Presentation in winter or early spring
  • History of exposure

Diagnosis

Not High-Risk Patients

Probability of group A beta hemolytic streptococci (GABHS): Low
Testing: None
Treatment: Symptomatic treatment only. Avoid antibiotics.

Probability of GABHS: Intermediate or High
Testing: Throat Culture (TC) OR Rapid Screen
Treatment: If TC is positive, use antibiotics.
If TC is negative, use symptomatic treatment only. Avoid antibiotics.
If treatment is started and culture result is negative, stop antibiotics.
If Rapid Screen is positive, use antibiotics.
If Rapid Screen is negative, culture1 and only use antibiotics if throat culture is positive.

1Culture optional for age 16 and over

High Risk Patients (history of rheumatic fever or household contact)

Start antibiotics immediately. If throat culture is obtained and is negative, stop antibiotics.

Treatment

Preferred Treatment for Strep Pharyngitis

  1. Penicillin VK: 250–500 mg twice or three times daily (bid-tid) x 10 days
  2. Amoxicillin: 20–40 mg/kg/day divided tid x 10 days [A]
  3. Benzathine penicillin G intramuscularly (IM) x 1: 600,000 units for weight < 60 lbs; 1.2 million units for weight > 60 lbs
  4. If allergic to penicillin: erythromycin ethyl succinate: 40 mg/kg/day two-four times daily (bid-qid) (max 1 g/day) x 10 days
  5. With oral antibiotics, a full 10 day course is required

Alternative Treatment for Strep Pharyngitis

  1. Cephalexin 15 to 50 mg/kg/day divided bid or tid x 10 days

Re-Evaluate/Referral

  1. If failure to respond clinically after 48 hours of treatment, rule out peritonsillar or retropharyngeal abscess. If present, prompt otolaryngology (ENT) evaluation is recommended.
  2. Assess the potential for a compliance problem.

Definitions:

Levels of Evidence for the Most Significant Recommendation

  1. Randomized controlled trials
  2. Controlled trials, no randomization
  3. Observational studies
  4. Opinion of expert panel

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Michigan Quality Improvement Consortium. Acute pharyngitis in children. Southfield (MI): Michigan Quality Improvement Consortium; 2007 Jan. 1 p.

ADAPTATION

DATE RELEASED

2004 Apr (revised 2007 Jan)

GUIDELINE DEVELOPER(S)

Michigan Quality Improvement Consortium - Professional Association

SOURCE(S) OF FUNDING

Michigan Quality Improvement Consortium

GUIDELINE COMMITTEE

Michigan Quality Improvement Consortium Medical Director's Committee

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Physician representatives from participating Michigan Quality Improvement Consortium health plans, Michigan State Medical Society, Michigan Osteopathic Association, Michigan Association of Health Plans, Michigan Department of Community Health, and Michigan Peer Review Organization

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Michigan Quality Improvement Consortium. Acute pharyngitis in children. Southfield (MI): Michigan Quality Improvement Consortium; 2004 Apr. 1 p

GUIDELINE AVAILABILITY

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI on November 28, 2005. The updated information was verified by the guideline developer on December 19, 2005. This NGC summary was updated by ECRI on October 16, 2006. The updated information was verified by the guideline developer on November 3, 2006. This NGC summary was updated by ECRI Institute on July 11, 2007. The updated information was verified by the guideline developer on July 16, 2007.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which may be reproduced with the citation developed by the Michigan Quality Improvement Consortium.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo